InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (57 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
57
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Kumar Neil, Chief Executive Officer. Officer active across 1 company, notably BridgeBio Pharma, Inc.. Cumulatively, 84 reports have been recorded. Breakdown: 0 buy · 57 sells. Total volume traded: €46.8m. History available since 5 January 2023. The latest transaction was filed on 18 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kumar Neil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations84 total
1,900 shares@ US$81.1494Common StockSEC:0001470831-26-000848:0
17,279 shares@ US$82.2104Common StockSEC:0001470831-26-000848:1
14,602 shares@ US$82.9922Common StockSEC:0001470831-26-000848:2
1,199 shares@ US$83.7732Common StockSEC:0001470831-26-000848:3
8,100 shares@ US$83.8588Common StockSEC:0001470831-26-000848:4
1,800 shares@ US$84.6867Common StockSEC:0001470831-26-000848:5
100 shares@ US$85.65Common StockSEC:0001470831-26-000848:6
33,544 sharesCommon StockSEC:0001470831-26-000836:0
19,599 sharesCommon StockSEC:0001470831-26-000836:1
11,554 sharesCommon StockSEC:0001470831-26-000836:2
6,520 sharesCommon StockSEC:0001470831-26-000836:3
36,237 shares@ US$79.860.019% mcap5.5% of flowCommon StockSEC:0001470831-26-000836:4
2,200 shares@ US$65.72020.0009% mcap0.4% of flowCommon StockSEC:0001470831-26-000523:0
1,429 shares@ US$66.7230.0006% mcap0.3% of flowCommon StockSEC:0001470831-26-000523:1
15,921 shares@ US$67.73780.0067% mcap3.0% of flowCommon StockSEC:0001470831-26-000523:2
450 shares@ US$68.26970.0002% mcap0.1% of flowCommon StockSEC:0001470831-26-000523:3
15,921 shares@ US$67.73770.0067% mcap3.0% of flowCommon StockSEC:0001470831-26-000523:6
7,147 shares@ US$67.1990.0030% mcap1.3% of flowCommon StockSEC:0001470831-26-000523:8
8,437 shares@ US$67.88480.0036% mcap1.6% of flowCommon StockSEC:0001470831-26-000523:9
4,416 shares@ US$68.95930.0019% mcap0.9% of flowCommon StockSEC:0001470831-26-000523:10
7,148 shares@ US$67.1990.0030% mcap1.3% of flowCommon StockSEC:0001470831-26-000523:11
4,415 shares@ US$68.95930.0019% mcap0.9% of flowCommon StockSEC:0001470831-26-000523:13
2,200 shares@ US$65.72020.0009% mcap0.4% of flowCommon StockSEC:0001470831-26-000523:4
450 shares@ US$68.26970.0002% mcap0.1% of flowCommon StockSEC:0001470831-26-000523:7
1,429 shares@ US$66.7230.0006% mcap0.3% of flowCommon StockSEC:0001470831-26-000523:5
25 of 84 declarations
About Kumar Neil
Kumar Neil is Président et Directeur Général and Chief Executive Officer of BridgeBio Pharma, Inc. He has 72 filings in total, and across the sampled recent filings the dominant transaction nature is sell, with €0 of purchases and €43,600,562 of sales between 2021-05-18 and 2026-06-08.
